1. Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands
2. Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands
3. Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
4. School of Social Policy, University of Peloponnese, Corinth, Greece
5. Institute of Medical & Chemical Laboratory Diagnostics, Center of Molecular Diagnostics & Genetics, Elisabethinen Hospital Linz, Linz, Austria
6. Centre for Health Economics & Medicines Evaluation, Bangor University, North Wales, UK
7. Centre for Medical Technology Assessment, Linköping University, Linköping, Sweden
8. Democritus University of Thrace, Alexandroupolis, Greece
9. University of Liverpool, Liverpool, UK
10. Department of Public Health & HTA, UMIT – University for Health Sciences, Medical Informatics & Technology, Hall i.T., Austria and ONCOTYROL – Center for Personalized Cancer Medicine, Innsbruck, Austria and Department of Health Policy & Management, Harvard School of Public Health, Boston, MA, USA and Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
11. Universität Ulm, Ulm, Germany
12. Department of Medical Sciences, Clinical Pharmacology, Uppsala University, Uppsala, Sweden
13. Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, PO Box 80 082, 3508 TB Utrecht, The Netherlands.